Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Inspire Pharma 3Q loss narrows on Azasite sales
Yahoo/AP
Thursday, November 4, 2010 - 11:11am
tags:
earnings, Inspire
Judge Upholds Verdict Against Pfizer Over Neurontin
Pharmalot
Thursday, November 4, 2010 - 11:09am
tags:
Pfizer, Neurontin, epilepsy
Celera Misses, Lowers Outlook
Yahoo/Zacks.com
Thursday, November 4, 2010 - 11:07am
tags:
Celera, earnings
Loss at REGN Wider than Expected
Yahoo/Zacks.com
Wednesday, November 3, 2010 - 7:17pm
tags:
earnings, Regeneron, Sanofi, AstraZeneca
Par Pharma Shares Popped: What You Need to Know
Motley Fool
Wednesday, November 3, 2010 - 7:16pm
tags:
Par Pharmaceutical
Alnylam takes wider 3Q loss as testing costs grow
Yahoo/AP
Wednesday, November 3, 2010 - 7:13pm
tags:
earnings, Alnylam
[video]Amgen in Focus
Yahoo/CNBC
Wednesday, November 3, 2010 - 7:00pm
tags:
Kevin Sharer, Amgen, Pharma CEOs, healthcare reform
Dendreon: Provenge Sales, Guidance Fall Short
TheStreet.com
Wednesday, November 3, 2010 - 6:57pm
tags:
Dendreon, earnings, Provenge
Cell Therapeutics gets NASDAQ reprieve
Bizjournals.com
Wednesday, November 3, 2010 - 1:54pm
tags:
NASDAQ, Cell Therapeutics
Judge combines suits against Pfizer-King merger
Fierce Pharma
Wednesday, November 3, 2010 - 11:46am
tags:
Pfizer, shareholders, King, lawsuits, M&A
Why do Pharmaceutical Sales Representatives hate Scripted Sales Presentations?
Pharmareform
Wednesday, November 3, 2010 - 11:25am
tags:
drug reps
Lilly CEO Calls for a 'Wave of Invention' to Reduce the Toll of Diabetes
Yahoo
Wednesday, November 3, 2010 - 10:49am
tags:
Pharma CEOs, Eli Lilly, diabetes, John Lechleiter
Grifols Slumps on The Deal Report That U.S. May Seek to Block Talecris Buy
Bloomberg
Wednesday, November 3, 2010 - 10:47am
tags:
Grifols, Talecris, M&A
Drugmakers, Whistleblowers And The SEC
Pharmalot
Wednesday, November 3, 2010 - 10:46am
tags:
whistleblowers, SEC
Simcere and Bristol-Myers Squibb Enter Innovative Partnership to Develop Early-Stage Oncology Compound
Yahoo
Wednesday, November 3, 2010 - 10:44am
tags:
Simcere, Bristol-Myers Squibb, China, oncology, cancer
Pharma layoffs drop to 1,929 in October
Fierce Pharma
Wednesday, November 3, 2010 - 8:18am
tags:
layoffs
Novartis's Onbrez better than Pfizer drug in COPD
Reuters
Wednesday, November 3, 2010 - 8:17am
tags:
Novartis, Onbrez, Pfizer, COPD
Biogen laying off 13 percent of its work force
Yahoo/AP
Wednesday, November 3, 2010 - 7:53am
tags:
Biogen Idec, layoffs
Lilly Announces China R&D Center in Major Strategic Departure
Seeking Alpha
Wednesday, November 3, 2010 - 7:48am
tags:
Eli Lilly, China, R&D
Time to Sell Amgen?
Motley Fool
Wednesday, November 3, 2010 - 6:57am
tags:
Amgen

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.